Extended-spectrum β-lactamase (ESBL) producing gram-negative bacilli are a growing
concern in human medicine today. When producing these enzymes, organisms (mostly K. …

… Since first reported in Europe in the early 1980s, extended-spectrum β-lactamases (ESBLs)
have spread worldwide. When producing these broad-spectrum plasmid-encoded enzymes, …

… In summary, microbiology laboratories and clinicians need to be aware of the presence
of ESBL-producing organisms in their hospital and should conduct surveillance studies to as…

… issue in the clinical microbiology laboratory. Ceftazidime must … -lactamase inhibitor compounds
and oxymino-beta-lactam … clinicians, infection control practitioners and microbiologists …

… The purpose of this review is to focus on the clinical aspects of ESBL production, with an
emphasis on the implications for clinical microbiology laboratories, hospital molecular …

… ‘broad spectrum’, when both reference substrates were hydrolysed at similar rates. Among
the broad-spectrum … sources of acquired resistance to the broad-spectrum penicillins [2]. TEM-…

… cephalosporin cannot predict resistance to other expanded-spectrum cephalosporins (8, …
expandedspectrum cephalosporins when the guidelines of the National Committee for Clinical …

… Biochemical sequence analyses of GES-1, a novel class A extended-spectrum βlactamase,
and … among Enterobacteriaceae by use of semiautomated microbiology systems and manual …

… Microbiology & epidemiology overview … In the varied and complex world of β-lactamases,
extended-spectrum β-lactamases (ESBLs) have played a leading role in the clinical field in …

… major cause of resistance to expanded-spectrum β-lactam antibiotics. Since their …
clinical microbiology laboratory and include both phenotypic and genotypic tests to detect β-lactamases…